| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Thomas M Maddox | |
| Maggie N Tillquist | |||
| P2860 | cites work | Prosthetic heart valves: selection of the optimal prosthesis and long-term management | Q28236110 |
| Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). | Q31881301 | ||
| Prosthetic heart valves and pregnancy | Q34182798 | ||
| Choice of prosthetic heart valve for adult patients | Q35090075 | ||
| Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses | Q35581325 | ||
| Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation | Q35582935 | ||
| Decision-making in aortic valve replacement: bileaflet mechanical valves versus stented bioprostheses | Q36817444 | ||
| Choice of prosthetic heart valve in adults an update | Q37761415 | ||
| Observed and relative survival after aortic valve replacement | Q38497383 | ||
| Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention | Q40844377 | ||
| Incorporating risk attitude into Markov-process decision models: importance for individual decision making | Q41528439 | ||
| Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial | Q43413859 | ||
| Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind? | Q44081173 | ||
| A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease | Q45336171 | ||
| Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty. | Q45946961 | ||
| Aortic valve replacement in octogenarians: is biologic valve the unique solution? | Q46690876 | ||
| ??? | Q28255148 | ||
| Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort. | Q50561332 | ||
| Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation. | Q50672496 | ||
| Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. | Q51008134 | ||
| Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. | Q51079648 | ||
| Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement. | Q51191018 | ||
| Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: Weighing lifetime anticoagulant-related event risk against reoperation risk | Q57916681 | ||
| Does the type of biological valve affect patient outcome? | Q57916736 | ||
| Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery | Q58854488 | ||
| Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy | Q69742234 | ||
| Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients | Q70147208 | ||
| Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators | Q71016449 | ||
| The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics | Q71064706 | ||
| Prosthetic heart valves | Q71178091 | ||
| Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy | Q71264573 | ||
| Fourteen-year experience with homovital homografts for aortic valve replacement | Q71873353 | ||
| Allograft aortic valve replacement: Long-term follow-up | Q71986720 | ||
| Actuarial versus actual risk of porcine structural valve deterioration | Q72736315 | ||
| Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis | Q73392763 | ||
| Comparative clinical outcomes with St. Jude Medical, Medtronic Hall and CarboMedics mechanical heart valves | Q73941529 | ||
| Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy) | Q74019320 | ||
| Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin | Q77199911 | ||
| Hemodynamic factors affecting the fate of valvular bioprosthesis | Q84151063 | ||
| Postoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trial? | Q84393716 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 91-99 | |
| P577 | publication date | 2011-02-17 | |
| P1433 | published in | Patient Preference and Adherence | Q7144972 |
| P1476 | title | Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement | |
| P478 | volume | 5 |
| Q57044478 | Aortic valvular imaging with cardiovascular magnetic resonance: seeking for comprehensiveness |
| Q99711283 | Bicuspid Aortic Valve and Endothelial Dysfunction: Current Evidence and Potential Therapeutic Targets |
| Q36829784 | Bioprosthetic versus mechanical prostheses for valve replacement in end-stage renal disease patients: systematic review and meta-analysis |
| Q33906071 | Cardiologist and cardiac surgeon view on decision-making in prosthetic aortic valve selection: does profession matter? |
| Q55616395 | Effect of glutaraldehyde based cross-linking on the viscoelasticity of mitral valve basal chordae tendineae. |
| Q55085664 | Fabrication and In Vitro Characterization of a Tissue Engineered PCL-PLLA Heart Valve. |
| Q35174201 | Impact of recipient-related factors on structural dysfunction of xenoaortic bioprosthetic heart valves |
| Q93112010 | Long-term outcome after mitral valve replacement using biological versus mechanical valves |
| Q41489828 | Nanopatterned acellular valve conduits drive the commitment of blood-derived multipotent cells. |
| Q36662471 | Prosthetic heart valve selection in women of childbearing age with acquired heart disease: a case report |
| Q90701310 | Radiopaque preventive landmarks' placement during stentless bioprosthesis implantation |
| Q50194074 | Surgical Treatment of Valvular Heart Disease: Overview of Mechanical and Tissue Prostheses, Advantages, Disadvantages, and Implications for Clinical Use. |
| Q33874373 | Trends in aortic valve replacement for elderly patients in the United States, 1999-2011. |
Search more.